N-tricyclic derivatives of azetidine and pharmaceutical composit

Details N-tricyclic derivatives of azetidine and pharmaceutical composit N-tricyclic derivatives of azetidine and pharmaceutical composit

1976-11-02

1978-03-07

Jaisle, Cecilia M. S.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Allergen or component thereof

260239A, 260268TR, 26029357, 26029358, 26029362, 2603265CA, 2603265SA, 26032681, 26032685, 260327B, 260333, 424244, 42424851, 424250, 424267, 424274, 424275, 424278, 4242485, 42424856, 42424857, 42424858, 4242484, 544111, C07D40904, A61K 3139

Patent

active

040780724

ABSTRACT:
Novel N-tricyclic derivatives of azetidine are disclosed of the general formula: ##STR1## WHERE A is a --CH.sub.2 --S-- or --S--CH.sub.2 -- group, the remaining substituents being defined in the specification. Illustrative is the compound 1-[11-(6,11-dihydro-dibenzo [b,e] thiopinyl)]-3-methylamino-azetidine. The compounds are useful for their anti-depressant, anti-convulsant and anxiolytic activities.

REFERENCES:
patent: 3758528 (1973-09-01), Malen et al.

Affiliated with

Also associated with

Rating

N-tricyclic derivatives of azetidine and pharmaceutical composit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-tricyclic derivatives of azetidine and pharmaceutical composit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-tricyclic derivatives of azetidine and pharmaceutical composit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2020891